Godfrey Barabona

Has grant

Assistant professor

Kumamoto University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Microbiology Microbiology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Godfrey Barabona is an Assistant Professor at Kumamoto Gakuen University, Japan. His research primarily focuses on HIV-1 infectivity, drug resistance in sub-Saharan Africa, and the immunological responses related to viral infections. Recently, he has contributed to studies examining the neutralizing activity against SARS-CoV-2 variants and investigating cardiovascular disease risk factors among HIV-infected populations in Tanzania.

Recent Grants

Grant: Close

Dr Barabona is a clinician and an infectious diseases researcher with specific interest human viral pathogen including HIV, SAR-COV-2, hepatitis and Human Herpes Viruses. In his research career, he has studied the genetic variability of HIV strains that are circulation in the hyperendemic region of East Africa and its relationship to the viral adaptation to the host. In addition, Dr Barabona is conducting studies to investigate HIV-related inflammation and role of viral co-infections and currently SAR-COV-2 infections in the context of East African population.

Open Date: 2022-04-01

Close Date: 2025-04-01

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (2)

Takamasa Ueno

Professor

Kumamoto University

JAPAN

View details

Yasumasa Iwatani

Nagoya University Graduate School of Medicine

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Godfrey Barabona

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Relative resistance of patient-derived envelope sequences to SERINC5-mediated restriction of HIV-1 infectivity

Dolutegravir resistance in sub-Saharan Africa: should resource-limited settings be concerned for future treatment?

Evaluation of Neutralizing Activity against Omicron Subvariants in BA.5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated Cytopathic Assay

Hypertension and traditional risk factors for cardiovascular diseases among treatment naïve HIV- infected adults initiating antiretroviral therapy in Urban Tanzania

Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey

Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike

Advanced baseline immunosuppression is associated with elevated levels of plasma markers of fungal translocation and inflammation in long-term treated HIV-infected Tanzanians

Phenotypic and Genotypic Co-receptor Tropism Testing in HIV-1 Epidemic Region of Tanzania Where Multiple Non-B Subtypes Co-circulate

Seroprevalence of Human Herpesvirus Infections in Newly Diagnosed HIV-Infected Key Populations in Dar es Salaam, Tanzania

Circulating HIV-1 Integrase Genotypes in Tanzania: Implication on the Introduction of Integrase Inhibitors-Based Antiretroviral Therapy Regimen

Collaborators (2)

Takamasa Ueno

Yasumasa Iwatani

Make your next move.